1. Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3-hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester
2. Cai, X.; Cheah, S.; Chen, S. M.; Eckman, J.; Ellis, J.; Fisher, R.; Fura, A.; Grewal, G.; Hussion, S.; Ip, S.; Killian, D. B.; Garahan, L.-L.; Lounsbury, H.; Qian, C. G.; Scannell, R. T.; Yaeger, D.; Wypij, D. M.; Yeh, C. G.; Young, M. A.; Yu, S. X. Abstracts of Papers of the American Chemical Society, 1997; 214, 214-MEDI.
3. Press release from Millenium Pharmaceuticals, Cambridge, USA, 10th October, 2000.
4. Acetogenins from Annonaceae: recent progress in isolation, synthesis and mechanisms of action
5. Strategy and Methodology Development for the Total Synthesis of Polyether Ionophore Antibiotics